MOUNJARO

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, France, Ireland, Israel, Italy, Japan, Lithuania, Romania, UK.

Active ingredients

The drug MOUNJARO contains one active pharmaceutical ingredient (API):

1	Tirzepatide UNII OYN3CCI6QE - TIRZEPATIDE
	Tirzepatide is a long acting GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic α and β endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation.
	Read more about Tirzepatide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MOUNJARO Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BX16		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02532891, 02532905, 02532913, 02532921, 02532948, 02532956
EE	Ravimiamet	1894473, 1894484, 1894495, 1894507, 1894518, 1894529, 1894530, 1894541, 1894552, 1894563, 1894574, 1894585, 1894596, 1894608, 1894619, 1894620, 1894631, 1894642
FR	Base de données publique des médicaments	60930150, 61022011, 63816465, 63925443, 64061756, 67657964
IL	מִשְׂרַד הַבְּרִיאוּת	9229, 9230, 9231, 9232, 9233, 9234
IT	Agenzia del Farmaco	050357019, 050357021, 050357033, 050357045, 050357058, 050357060, 050357072, 050357084, 050357096, 050357108, 050357110, 050357122, 050357134, 050357146, 050357159, 050357161, 050357173, 050357185
JP	医薬品医療機器総合機構	2499422G1024, 2499422G2020, 2499422G3027, 2499422G4023, 2499422G5020, 2499422G6026
LT	Valstybinė vaistų kontrolės tarnyba	1095600, 1095601, 1095602, 1095603, 1095604, 1095605, 1095606, 1095607, 1095608, 1095609, 1095610, 1095611, 1095612, 1095613, 1095614, 1095615, 1095616, 1095617
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69218001, W69218002, W69218003, W69219001, W69219002, W69219003, W69220001, W69220002, W69220003, W69221001, W69221002, W69221003, W69222001, W69222002, W69222003, W69223001, W69223002, W69223003
US	FDA, National Drug Code	0002-1457, 0002-1460, 0002-1471, 0002-1484, 0002-1495, 0002-1506